FDA Submits Collection of Information for Review Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, in connection with applications for FDA approval to market a new drug and postmarketing reports, including information about authorized generic drugs.